Trasplante hepático en cáncer de hígado. Indicaciones

Hepatic transplantation in liver cancer. Indications

• Dioverys Hinestroza-Finol Hospital Universitario de Maracaibo https://orcid.org/0000-0003-1526-4386
• Dilmo Hinestroza-Finol Hospital Clínico de Maracaibo https://orcid.org/0000-0001-5893-1535
• Ranced Vivas-Arellano Hospital Clínico de Maracaib https://orcid.org/0000-0002-4026-3310
• Isabel Urdaneta-Durand Hospital Clínico de Maracaibo https://orcid.org/0000-0002-0533-6828
• Dilmo Hinestroza-Valbuena Universidad del Zulia https://orcid.org/0000-0003-1615-2888

DOI: https://doi.org/10.5281/zenodo.5120878

Resumo

El trasplante ortotópico de hígado (TOH) ha evolucionado con el paso del tiempo hacia un procedimiento con altas tasas de sobrevida. Esto, el desarrollo del tratamiento oncológico y la selección adecuada de pacientes por los criterios de Milán han ido colocando al TOH como una herramienta aceptada para el tratamiento del cáncer hepático tanto primario como metastásico. Sin embargo, algunos autores consideran estrictos estos criterios, impulsando su modificación e inclusión del comportamiento biológico del tumor, expandiendo así la elegibilidad de pacientes.

Referências

Phillipe Abreu, Andre Gorgen, Graziano Oldani, Taizo Hibi, Gonzalo Sapisochin. Recent advances in liver transplantation for cancer: The future of transplant oncology. 2019, 5. Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).

Wei Chieh Kow. Transplantation versus liver resection in patients with hepatocellular carcinoma. Transl Gastroenterol Hepatol. (2019) 4:33. http://dx.doi.org/10.21037/tgh.2019.05.06

Ka-Wan K, Hiu-Ching K, Siu-Ho K. (2021). Expanding Indications for Liver Transplant: Tumor and Patient Factors. Gut and Liver; 15 (1):19-30. https://pubmed.ncbi.nlm.nih.gov/32102130/

Wang L, Zheng S. (2018). Advances in predicting the prognosis of hepatocellular carcinoma recipients after liver transplantation. Journal of Zhejiang University-science B (Biomedicine & Biotechnology); 19(7):497- 504. https://pubmed.ncbi.nlm.nih.gov/29971988/

Lingiah VA, Niazi M, Olivo R, Paterno F, Guarrera JV, Pyrsopoulos NT. Liver Transplantation Beyond Milan Criteria. J Clin Transl Hepatol; (2020) 8(1):69–75. doi: 10.14218/JCTH.2019.00050.

Hae Won Lee, and Kyung-Suk Suh. Liver transplantation for advanced hepatocellular carcinoma. Clinical and Molecular Hepatology 2016;22:309-318.
Pavel M, Fuster J. Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions. World J Gastroenterol; (2018) 24 (32): 3626-3636. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113720/

Xinyu Li, Lei Huang, Xisheng Leng. Analysis of prognostic factors of more/equal to 10 years of survival for liver cancer patients after liver transplantation. Journal of Cancer Research and Clinical Oncology (2018) 144:2465–2474.

Matteo Ravaioli y col. Liver transplantation for hepatic tumors: a systematic review. World J Gastroenterol 2014 May 14; 20(18): 5345-5352.

Andre Gorgen et al. The New Era of Transplant Oncology: Liver Transplantation for Nonresectable Colorectal Cancer Liver Metastases. Canadian Journal of Gastroenterology and Hepatology Volume 2018, Article ID 9531925, 7 pages.

Pal-Dag Line, Morten Hagness, Svein Dueland. The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases. Canadian Journal of Gastroenterology and Hepatology Volume 2018, Article ID 8547940, 5 pages.

Giuseppe Nigri. Treatment options for PNET liver metastases: a systematic review. World Journal of Surgical Oncology (2018) 16:142.